Allergy Immunotherapies Market Forecast Report 2021-2026: Global Share, Size, Growth, Key Players, Trends, Industry Demand, and Outlook

on
Allergy Immunotherapies Market

According to the latest report by IMARC Group titled, “Allergy Immunotherapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, The global allergy immunotherapies market reached a value of US$ 2.3 Billion in 2020. Looking forward, IMARC Group expects the global allergy immunotherapies market to reach a value of US$ 4.10 Billion by 2026, exhibiting a CAGR of 10.50% during 2021-2026. Allergy immunotherapies, also referred to as allergy shots, refer to treatments used for curing life-threatening allergic reactions to stinging insects. These therapies involve the repeated administration of specific allergens to a patient until their immune system modifies accordingly.

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviors of the consumers globally–our estimates about the latest market trends and forecast values after considering the impact of this pandemic. These observations will be integrated into the report.

Request for a free sample copy of this report: https://www.imarcgroup.com/allergy-immunotherapies-market/requestsample

Market Trends:

Nowadays, the vast majority of people worldwide are suffering from different types of allergies, including contact dermatitis, allergic asthma, allergic rhinitis, and anaphylaxis. This has augmented the demand for medical treatments, such as allergy immunotherapy. Apart from this, there has been a rise in the awareness among consumers about several health benefits of allergy immunotherapy, such as enhancing microbial tolerance, improving immunological abilities, reducing inflammation and irritation, and offering long-term relief. Owing to this, a large number of patients are opting for allergy immunotherapies. Moreover, the rising research and development (R&D) activities in the healthcare sector have enabled the leading pharmaceutical firms to introduce drug for treating an array of allergies successfully. This will continue to catalyze the growth of the market in the forthcoming years.

Buy full report with table of contents: https://bit.ly/3oazoNn

Key Market Segmentation:

Some of the top key players in the market are: 

  1. ALK-Abello A/S
  2. Allergy Therapeutics
  3. Stallergenes Greer
  4. HAL Allergy Group
  5. DBV Technologies
  6. Merck Group
  7. Aimmune Therapeutics
  8. Circassia Pharmaceuticals
  9. Anergis SA
  10. Biomay AG, etc.

Breakup by Treatment Type:

  1. Subcutaneous Immunotherapy (SCIT)
  2. Sublingual Immunotherapy (SLIT)

Breakup by Allergy Type:

  1. Allergic Rhinitis
  2. Asthma
  3. Food Allergy
  4. Venom Allergy
  5. Others

Breakup by Distribution Channel:

  1. Hospital Pharmacy
  2. Retail Pharmacy
  3. Online Pharmacy

Breakup by Region:

  1. Europe
  2. North America
  3. Asia Pacific
  4. Middle East and Africa
  5. Latin America

Key Highlights of the Report:

  1. Market Performance (2015-2020)
  2. Market Outlook (2021- 2026)
  3. Porter’s Five Forces Analysis
  4. Market Drivers and Success Factors
  5. SWOT Analysis
  6. Value Chain
  7. Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Other Report:

About us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Comments

Post a Comment